Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Revenue (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Serina Therapeutics (SER) Other Gross PP&E Adjustments (2017 - 2025)

Serina Therapeutics' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at -$674000.0 for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 912.05% to -$674000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$674000.0, a 912.05% decrease, with the full-year FY2025 number at -$674000.0, down 912.05% from a year prior.
  • Other Gross PP&E Adjustments hit -$674000.0 in Q4 2025 for Serina Therapeutics, down from $1.1 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for SER hit a ceiling of $1.1 million in Q3 2025 and a floor of -$690000.0 in Q4 2021.
  • Historically, Other Gross PP&E Adjustments has averaged $137411.8 across 5 years, with a median of -$32000.0 in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 2690.91% in 2024 and later crashed 912.05% in 2025.
  • Tracing SER's Other Gross PP&E Adjustments over 5 years: stood at -$690000.0 in 2021, then rose by 6.81% to -$643000.0 in 2022, then surged by 232.66% to $853000.0 in 2023, then crashed by 90.27% to $83000.0 in 2024, then crashed by 912.05% to -$674000.0 in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for SER at -$674000.0 in Q4 2025, $1.1 million in Q3 2025, and $860000.0 in Q2 2025.